Danish biotech Zealand Pharma is targeting the “next generation” of weight loss drugs as competitors pile into a market dominated by heavyweights Novo Nordisk and Eli Lilly.
Related Posts
Meet Xmodel-1.5: A Novel 1-Billion-Parameter Multilingual Large Model Pretrained on Approximately 2 Trillion Tokens
In today’s increasingly interconnected world, effective communication across languages is essential. However, many natural language processing (NLP) models still struggle…
A Step-by-Step Tutorial on Robustly Validating and Structuring User, Product, and Order Data with Pydantic in Python
In many modern Python applications, especially those that handle incoming data (e.g., JSON payloads from an API), ensuring that the…
China’s new rules are worrying insiders about how far Beijing will go on controlling critical metals
New export controls have shaken the critical minerals industry. Insiders are worried that Beijing will leverage its global supply chain…